Presentation is loading. Please wait.

Presentation is loading. Please wait.

Frontiers of anticoagulation therapy for atrial fibrillation

Published byHolly Leonard Modified over 6 years ago

Similar presentations

Presentation on theme: "Frontiers of anticoagulation therapy for atrial fibrillation"— Presentation transcript:

1 Frontiers of anticoagulation therapy for atrial fibrillation
Takeshi Yamashita, MD, PhD, FJCC  Journal of Cardiology  Volume 58, Issue 1, Pages 1-5 (July 2011) DOI: /j.jjcc Copyright © 2011 Japanese College of Cardiology Terms and Conditions

2 Figure 1 A schema showing the complex pharmacology of warfarin and the simple pharmacology of new anticoagulants. VK, vitamin K; VKOR, vitamin K epoxide reductase; CYP, cytochrome P450. Journal of Cardiology  , 1-5DOI: ( /j.jjcc ) Copyright © 2011 Japanese College of Cardiology Terms and Conditions

3 Figure 2 A comparison of strategy between CHADS2 score and CHA2DS2-VASc score. In both scoring systems, AF patients with 2 points or more are recommended for anticoagulation therapy. Most patients categorized into 1 point in CHADS2 score would move to 2 points in the new CHA2DS2-VASc score. Journal of Cardiology  , 1-5DOI: ( /j.jjcc ) Copyright © 2011 Japanese College of Cardiology Terms and Conditions

Download ppt "Frontiers of anticoagulation therapy for atrial fibrillation"

Similar presentations

Non-invasive and invasive evaluation of aortic valve area in 100 patients with severe aortic valve stenosis: Comparison of cardiac computed tomography.

Non-invasive and invasive evaluation of aortic valve area in 100 patients with severe aortic valve stenosis: Comparison of cardiac computed tomography.
Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.

Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.
Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,

Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome Hitoshi Minamiguchi, MD, Shinsuke Nanto, MD, PhD,

Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome Hitoshi Minamiguchi, MD, Shinsuke Nanto, MD, PhD,
A case of cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy awaiting heart transplant Sahika Hisaoka, MD, Tomoko Sugiyama-Kato,

A case of cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy awaiting heart transplant Sahika Hisaoka, MD, Tomoko Sugiyama-Kato,
Prolonged survival after surgery for cardiac metastasis from malignant melanoma Antoine Noel, intern, Claire Toquet, MD, Jacques Dewilde, MD Journal of.

Prolonged survival after surgery for cardiac metastasis from malignant melanoma Antoine Noel, intern, Claire Toquet, MD, Jacques Dewilde, MD Journal of.
Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
To Anticoagulate or not to Anticoagulate

To Anticoagulate or not to Anticoagulate
Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.
Volume 70, Issue 1, Pages (July 2017)

Volume 70, Issue 1, Pages (July 2017)
Volume 53, Issue 2, Pages (April 2009)

Volume 53, Issue 2, Pages (April 2009)
Volume 69, Issue 1, Pages (January 2017)

Volume 69, Issue 1, Pages (January 2017)
Volume 65, Issue 3, Pages (March 2015)

Volume 65, Issue 3, Pages (March 2015)
Volume 29, Issue 3, Pages (June 2013)

Volume 29, Issue 3, Pages (June 2013)
Subtherapeutic anticoagulation with dabigatran following Roux-en-Y gastric bypass surgery  Daniel Lee, MD, Zachariah DeFilipp, MD, Kenneth Judson, DO,

Subtherapeutic anticoagulation with dabigatran following Roux-en-Y gastric bypass surgery  Daniel Lee, MD, Zachariah DeFilipp, MD, Kenneth Judson, DO,
Volume 55, Issue 3, Pages (May 2010)

Volume 55, Issue 3, Pages (May 2010)

Similar presentations

Ads by Google